Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000912057-01-503468
Filing Date
2001-03-13
Accepted
2001-03-13 00:00:00
Documents
18
Period of Report
2001-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2037574zdef14a.htm DEF 14A 172049
2 G103627.JPG g103627.jpg GRAPHIC 86791
3 G796566.JPG g796566.jpg GRAPHIC 4245
4 G10428.JPG g10428.jpg GRAPHIC 5084
5 G288620.JPG g288620.jpg GRAPHIC 3803
6 G506699.JPG g506699.jpg GRAPHIC 5189
7 G96392.JPG g96392.jpg GRAPHIC 5242
8 G434362.JPG g434362.jpg GRAPHIC 4937
9 G530811.JPG g530811.jpg GRAPHIC 5385
10 G888923.JPG g888923.jpg GRAPHIC 5743
11 G226198.JPG g226198.jpg GRAPHIC 6717
12 G52104.JPG g52104.jpg GRAPHIC 5960
13 G685512.JPG g685512.jpg GRAPHIC 5399
14 G100423.JPG g100423.jpg GRAPHIC 4809
15 G635664.JPG g635664.jpg GRAPHIC 5325
16 G114739.JPG g114739.jpg GRAPHIC 34643
17 G519019.JPG g519019.jpg GRAPHIC 1261
18 G674535.JPG g674535.jpg GRAPHIC 4617
  Complete submission text file 0000912057-01-503468.txt   370450
Mailing Address
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 8479376100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-02189 | Film No.: 1567041
SIC: 2834 Pharmaceutical Preparations